Ikhithi yokuxilonga ye-D-dimer (Fluorencence Immunochrographic Assay)

Incazelo emfushane:


  • Isikhathi sokuhlola:Imizuzu engu-10-15
  • Isikhathi esivumelekile:Inyanga engu-24
  • Ukunemba:Bangaphezu kuka-99%
  • Ukucaciswa:1/25 Ukuhlolwa / Ibhokisi
  • Ukushisa kwesitoreji:2 ℃ -30 ℃
  • Imininingwane Yomkhiqizo

    Amathegi Omkhiqizo

    I-Diagnostic Kit ye-D-dimer(Fleorescence Immunochrographic Assay)
    Ngokusetshenziswa kokuxilongwa kwe-vitro kuphela

    Uyacelwa ukuthi ufunde leli phakethe Faka ngokucophelela ngaphambi kokusebenzisa futhi ulandele imiyalo ngokuqinile. Ukwethembeka kwemiphumela ye-Assay akunakuqinisekiswa uma kukhona ukuphambuka emiyalweni ekuleW kufakiwe.

    Ukusetshenziswa okuhlosiwe
    Ikhithi yokuxilonga ye-D-dimer (Fleorescence Immunochrohamaygraphic Assay is a Fleorescence Immunochrographic Assay for the Diant Sokuthola indawo ye-D-dimer (DD) ku-thrombosis yomuntu, isetshenziselwa ukubhekelwa kwe-thrombols, kanye nokuqapha kwe-thrombolytic Ukwelapha .Khlisayo isampula emihle kufanele iqinisekiswe ezinye izindlela. Lokhu kuhlola kuhloselwe ukusetshenziswa kwezempilo kuphela.

    Ukubeka kafushane
    I-DD ikhombisa umsebenzi we-fibrinolytic.Izizathu zokwanda kwe-DD: 1.Secondary hyperfibrinolys, njenge-hypercaaguagulation, isifo sezinhlamvu, ukwenqatshwa kwe-thrombolytic, ukwelashwa kwe-thrombolytic, imisebenzi ye-fibrinolysis emikhunjini ; 3.Myocardial infarction, infarction ye-cerebral, embolism ye-pulmonary, i-thrombosis ye-pulmonary, ukuhlinzwa, isimila, ukuncibilikisa ukubheja, ukutheleleka kanye ne-necrosis, njll kanye nezicubu ze-necrosis, njll.

    Umgomo wenqubo
    Ulwelwesi lwedivayisi yokuhlola luhlanganiswe ne-anti DD antiloy ku-Test Region kanye nembuzi anti Unogwaja IGG Antibody on the Control Regiody. I-Lable Pad ihlanganiswe yi-fluorescence ilebula anti did antibody kanye ne-rabbit igg kusengaphambili. Lapho uhlola isampula elifanele, i-DD Antigen yesampula ihlangana ne-fluorescence ilebula anti entibod, bese wenza umxube wokuzivikela. Ngaphansi kwesenzo se-Immunochrotography, ukugeleza okuyinkimbinkimbi kokuqondiswa kwephepha lokumunca, lapho kuyinkimbinkimbi kudlula esifundeni sokuhlola, kuhlanganiswe ne-anti DD coating antipody, amafomu amasha abumbana. Izinga le-DD lixhumeka kahle ngesiginali ye-fluorescence, futhi ukugcwala kwe-DD kwisampula yesampula kungatholwa yi-fluorescence immunoassay assay.

    Ama-reagents nezinto zokwenziwa

    25T Iphakethe Izakhi:
    Ikhadi lokuhlola ngawodwana ahlelwe nge-desiccant 25t
    Isampula dilients 25t
    Faka iphakheji 1

    Izinto ezidingekayo kodwa azinikeziwe
    Isithakongo esiqoqiwe sesampula, isibali sikhathi

    Ukuqoqwa kwesampula nesitoreji
    .Izinsalela ezivivinyiwe kungaba yinparlin anticoaagulant plasma noma i-Edta anticoagulant plasma.

    .According kumasu ajwayelekile ukuqoqa isampula. Isampula ye-serum noma ye-plasma ingagcinwa esiqandisini ku-2-8 ℃ ngezinsuku eziyi-7 days kanye ne-cropressoal
    .Aka amasampula agweme imijikelezo ye-freeze-thaw.

    Inqubo yokufa
    Uyacelwa ukuthi ufunde incwadi yokusebenza kwensimbi yokusebenza kwensimbi kanye nokufaka iphakheji ngaphambi kokuhlolwa.

    1.Lay ubeka wonke ama-reagents namasampula wokushisa kwegumbi.
    I-2.open them immune analyzer (Wiz-A101), faka ukungena ngemvume kwe-akhawunti ngokusho kwendlela yokusebenza yensimbi, bese ufaka isikhombimsebenzisi sokuthola.
    I-3.Sc Ikhodi Yokucacisa Ukuqinisekisa Into Yokuhlola.
    4.Thola ikhadi lokuhlola esikhwameni se-foil.
    5.Shuma ikhadi lokuhlola ekhadini lekhadi, scan ikhodi ye-QR, bese unquma into yokuhlola.
    I-6.Add 40μL serum noma isampula ye-plasma kwi-tampleent, uhlanganise kahle ..
    7.ADD 80μL isixazululo isampula yesampula kahle yekhadi.
    8.Chofoza inkinobho ethi "Ukuhlolwa okujwayelekile", ngemuva kwemizuzu eyi-15, ithuluzi lizobona ngokuzenzakalelayo ikhadi lokuhlola, lingafunda imiphumela kusuka esikrinini sokubonisa sensimbi, bese uqopha / phrinta imiphumela yokuhlola.
    9.Refer ekufundisweni kwe-immune analyzer (Wiz-A101).

    Amanani alindelwe
    Dd <0.5mg / l

    Kunconywa ukuthi ilebhu ngalinye ngalinye lasungulwa uhla lwalo olujwayelekile olumele abantu balo.

    Imiphumela yokuhlola nokutolika
    .Imininingwane engenhla ingumphumela wokuhlolwa kwe-DD reagent, futhi kuphakanyiswa ukuthi ilabhorethri ngalinye kufanele lisungule uhla lwamanani wokutholwa kwe-DD alungele inani labantu kulesi sifunda. Imiphumela engenhla ingeyokubhekiswa kuphela.

    .Imiphumela yale ndlela isebenza kuphela kumabanga okuthola amareferensi asungulwe kule ndlela, futhi akukho ukuqhathanisa okuqondile nezinye izindlela.
    Izici ze-.

    Ukugcinwa nokuqina
    I-1.Ikhithi iyizinyanga eziyi-18 zeShelf-Life kusuka ngosuku lokukhiqiza. Gcina amakhithi angasetshenziswanga ngo-2-30 ° C. Ungabazi. Ungasebenzisi ngaphezu kosuku lokuphelelwa yisikhathi.

    2.Ungakuvuli esikhwameni esivaliwe uze ulungele ukwenza isivivinyo, futhi ukuhlolwa okusetshenziswa okukodwa kuphakanyiswa ukuthi kusetshenziswe ngaphansi kwendawo edingekayo (lokushisa 2-35 ℃, umswakama we-40-90%) ngaphakathi kwamaminithi angama-60 ngokushesha ngangokunokwenzeka.
    3.Sample Diloulent isetshenziswa ngokushesha ngemuva kokuvulwa.

    Izexwayiso kanye nokuqapha
    1.Ikhithi kufanele ivalwe futhi ivikelwe kumswakama.

    2.ALL amasampula amahle azoqinisekiswa ezinye izindlela.
    3.All amasampula azophathwa njengokungcoliswa okungaba khona.
    4.Ungasebenzisi i-reagent ephelelwe yisikhathi.
    5.Ungavimbi ama-reagents phakathi kwama-kits ane-Lot ehlukile Cha ..
    6.Ungasebenzisi futhi amakhadi wokuhlola nanoma yiziphi izesekeli ezilahlwayo.
    7.Cisoptioperation, isampula ngokweqile noma elincane ingaholela ekuphaphemeni komphumela.

    LUkufanisa
    .S nganoma yisiphi ama-antibodies asegulayo e-Assay asebenzisa, kungenzeka ukuthi kuphazanyiswe ngama-antibodies angomuntu alwa nobuntu (Hama) ku-specimen. Izinhlobo ezivela ezigulini ezithole amalungiselelo ama-antibodies e-monoclonal yokuxilongwa noma ukwelashwa kungaqukatha uHama. Izinhlobo ezinjalo zingadala imiphumela emibi noma engamanga.

    Umphumela wokuhlola we-.Lokhuwo we-. .
    .Lokhu i-realent isetshenziselwa kuphela ukuhlolwa kwe-serum ne-plasma. Kungase kungatholi umphumela onembile uma usetshenziselwa amanye amasampula anjenge-saliva nomchamo nokunye.

    Izici Zokusebenza

    Ubunoriti 0.2mg / l to10mg / l Ukuphambuka okuhlobene: -15% kuya ku-15%.
    I-Linear colloeffection coefflication: (R) ≥0.9900
    Ukuqonda nqo Izinga lokutakula lizoba ngaphakathi kwama-85% - 115%.
    -Phindaphiwe Cv≤15%
    Ukucacisa(Azikho izinto ezihlolwe empeshelweni ezihlotshiswe ku-Assay)

    -Thizelwayo

    Ukugxila okuphazamisayo

    I-FDP

    I-120mg / l

    VC

    I-2000mg / l

    I-Barbituric acid

    I-100mg / l

    REcabanga
    1.Hansen JH, et al.hama ukuphazamiseka nge-murine monoclonal antibody-based immunody [j] .j we-Clin immunoassay, 1993,16: 294-299.

    I-2.levinson ss.Imvelo yama-antibophilies ama-heterophilic kanye neqhaza ekuphazanyisweni kwe-immunoassay [j] .j we-mimunoassay, 1992,15: 108-114.

    Ukhiye wezimpawu ezisetshenzisiwe:

     t11-1 Kudivayisi yezokwelapha yokuxilongwa kwe-vitro
     tt-2 Umenzi
     tt-71 Gcina ngo-2-30 ℃
     tt-3 Usuku lokuphelelwa isikhathi
     tt-4 Ungaphinde usebenzise kabusha
     tt-5 Isiqapheliso
     tt-6 Bheka imiyalo yokusebenzisa

    Xiamen Wiz Biotech Co., Ltd
    Ikheli: 3-4 phansi, i-No.16 yokwakha, indawo yokusebenzela ye-bio-medical, 2030 wengjiao West Road, Haicang District, 3610266, xiamen, China
    I-TELE: + 86-592-6808278
    Ifeksi: + 86-592-6808279


  • Okwedlule:
  • Olandelayo: